1. Two cases of Francisella tularensis subspecies holartica prosthetic valve endocarditis, and review of the literature.
- Author
-
Talarmin JP, Rezig S, Grandiere Perez L, Artus M, Blanchi S, Guerpillon B, Beaudron A, Boisset S, Dubée V, and Caspar Y
- Subjects
- Humans, Male, Middle Aged, Prosthesis-Related Infections microbiology, Prosthesis-Related Infections drug therapy, Prosthesis-Related Infections diagnosis, Heart Valve Prosthesis microbiology, Heart Valve Prosthesis adverse effects, Female, Aged, Treatment Outcome, Ciprofloxacin therapeutic use, Gentamicins therapeutic use, Francisella tularensis isolation & purification, Francisella tularensis drug effects, Francisella tularensis genetics, Tularemia diagnosis, Tularemia drug therapy, Tularemia microbiology, Endocarditis, Bacterial microbiology, Endocarditis, Bacterial drug therapy, Endocarditis, Bacterial diagnosis, Anti-Bacterial Agents therapeutic use
- Abstract
Francisella tularensis endocarditis is rare and difficult to diagnose, and only a few cases have been described. We report two new cases of endocarditis due to F. tularensis subsp. holarctica, with a favorable evolution after appropriate antibiotic therapy and valve replacement surgery, and review the 5 other cases reported in the literature. This rare infection may be suspected based on the local epidemiology and the patient's exposure factors. A regimen of ciprofloxacin and gentamicin, combined with surgical valve replacement if necessary, appears to be effective in treating F. tularensis endocarditis., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF